Tulsi Gabbard Resigns as Trumps Intelligence Chief to Care for Husband with Bone Cancer Gas Prices Hit 455 National Average Consumer Strategies to Mitigate Fuel Costs Dow Hits New Record Close Lifted by Falling Oil Prices as Iran Truce Hopes Grow Europe Faces Strategic Vulnerability as US Dominates Satellite and AI Infrastructure Warns Telecoms CEO Gift Nifty Signals Strong Start for Indian Equities as Global Sentiment Improves Over Weekend Pentagon Releases Decades of UFO Sightings Potential Implications for Defense and Technology Sectors JBI Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Absence SIDU Q1 2026 Earnings Space Company Reports Narrowed Loss as Stock Surges 24 Aprea Therapeutics Inc APRE Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid Clinical Progress TONX Q1 2026 Earnings Massive EPS Beat Amid Sharp PostReport Decline GLDD Q4 2025 Earnings Strong EPS Surprise of 545 as Dredging Operations Beat Estimates BZAI Q1 2026 Earnings EPS Beat Despite Narrow Loss US Physical Therapy USPH Slips Slightly as Stock Consolidates Near Key Support Cimpress CMPR Surges 76 Testing Key Resistance After Strong Move UMB Financial Surges 24 as Shares Approach Resistance at 14111 COCO Climbs 1 as Support Holds Can Vita Coco Company Break Above 8065 Spartacus Acquisition Corp II Unit TMTSU Trading Flat Near NAV as Merger Search Continues Berkshire Hathaway Makes Major Portfolio Shift New Stakes in Delta Air Lines and Alphabet Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones Intercure Ltd INCR Rallies 48 Testing Key Resistance at 097 AIFU Q3 2023 Earnings Strong EPS Amid Market Volatility ATRA Q1 2026 Earnings Loss Narrows More Than Expected Amid Ongoing Pipeline Progress OEC Q1 2026 Earnings Shares Rally Despite Steep EPS Miss CHD Q1 2026 Earnings EPS Beats Estimates Stock Gains 14 RSG Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick ThredUp TDUP Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response SRRK Q1 2026 Earnings WiderthanExpected Loss Amid Clinical Progress